Research advances of corneal collagen cross-linking in the treatment of corneal diseases
10.3760/cma.j.issn.2095-0160.2020.03.016
- VernacularTitle:角膜胶原交联术治疗角膜病的新进展
- Author:
Guizhen JIA
1
;
Mengya CHENG
;
Linnong WANG
Author Information
1. 南京医科大学附属南京医院（南京市第一医院）眼科 210006（现在南京医科大学附属儿童医院眼科 210008）
- From:
Chinese Journal of Experimental Ophthalmology
2020;38(3):245-249
- CountryChina
- Language:Chinese
-
Abstract:
Corneal collagen cross-linking (CXL) has been proved to be a very safe and effective technique to halt the progression of many cornea diseases, such as ectasia disease, infectious keratitis and ametropia.CXL techniques include conventional CXL, accelerated CXL, transepithelial CXL and photochemical CXL.CXL can prevent the progression of dilated keratopathy, postpone or avoid corneal transplant surgery, and has an auxiliary function in the treatment of bullous keratopathy, infectious keratitis except herpes virus infection, and ametropia.CXL is not effective for patients with ocular herpes virus infection and patients with thin cornea and may even worsen the development of the disease.This review summarized the advantages and disadvantages of common CXL techniques, indications, contraindications, and complications, which may help enhancing the clinical application of CXL and reducing its complications.
